Abstract:
The present invention relates to a nano-sized material that can provide contrast enhancement for multple imaging methods and also deliver therapeutic molecules such as nucleic acids or chemo drugs to diseased sites such as cancer. In particular, the present invention relates to nano-sized synthetic calcium phosphates and calcium apatite nanomaterials showing simultaneous contrast for at least any two of the medical imaging modalities including radio, raman-, near-infrared fluroscence-, magnetic resonance and x-ray-imaging.
Abstract:
A composite implant (100) for providing simultaneous magnetic resonance imaging (MRI) and computed tomographic (CT) imaging contrast is disclosed. The composite implant (100) is formed of a calcium compound (120) in the form of nano or microparticles doped with a first dopant (126) configured to provide MRI contrast and a second dopant (127) configured to provide CT contrast. The calcium compound (120) is loaded onto a polymer gel matrix (110) and lyophilized to form a mass with 3-dimensionally interconnected porosity (102), configured to provide tissue integration and proliferation sites. Methods (200) of forming the composite implant (100) are also disclosed. The implant could be a scaffold (101) or bead (105) structured to enable treatment of human or animal patient for bone/cartilage injury or defect by implantation, with MRI and CT monitoring.
Abstract:
The present invention relates to aphotosensitizer-containing nanoparticle, comprising a photosensitizer covalently bonded throughout at least a part of said nanoparticle to the nanoparticle matrix material and incorporated therein in a quasi- aggregated state. The present invention furtherrelates to methods for producing the invention nanoparticles, and to methods ofkilling cancer cells by PDT treatment using the said nanoparticles.
Abstract:
The present invention relates to a nano-sized material that can provide contrast enhancement for multiple molecular imaging mthods and also deliver therapeutic nucleic acids or chemodrugs at a specific site of disease such as cancer. In particular, the present invention relates to a nanosized synthetic calcium apatite based materials showing contrast imaging for visible to near-infrared fluroscence, magnetic resonance imaging and x-ray imaging together with targeted delivery of nucleic acid drugs (DNA or RNA) to specific cancer types.
Abstract:
The present invention relates to a composition, method and kit for treatment of mycobacterial infections. The composition is made of a first agent including 1-3000 mg diosmin, diosmentin, or a pharmaceutically acceptable salt thereof and a second agent including 1-1500 mg of amoxicillin and 1-375 mg of clavulanic acid. The composition may optionally include one or more tuberculosis drugs. The composition may be formulated as an oral dosage form. Diosmin (or diosmetin) binds to and inhibits mycobacterial L,D transpeptidase 1 and 2 activity. The combination of diosmin (or diosmetin) with amoxicillin and clavulanic acid has superior and synergistic in vitro and in vivo anti-mycobacterial activity and is suitable for drug resistant forms of tuberculosis.
Abstract:
The invention discloses nanoparticles comprising compounds of calcium with anions such as phosphate, pyrophosphate, sulphate, silicate, carbonate, molybdate, or phosphosilicate that are doped with various ions. The nanoparticles are configured to produce heat (hyperthermia) under radio-wave (1KHz-1000GHz) exposure together with magnetism suitable for contrast imaging in MRI, X-ray absorption for computed tomography, near-infrared optical fluorescence for optical imaging, and/or radio-isotope emission for nuclear imaging or therapy. The nanoparticles can also be incorporated into micro-beads or other 3 dimensional scaffolds for image-guided (MRI, CT, NIR, nuclear) tissue regeneration, vascular or tumor embolization, and/or chemo/radio-embolization.
Abstract:
The present invention relates to compositions and methods for the treatment or prevention of autoimmune diseases such as demyelination disorders. The invention includes a composition comprising a peptide antigen comprising at least one beta (β) amino acid coupled to a carrier nano or microparticle of silica. In one embodiment the demyelination disorder is multiple sclerosis.
Abstract:
The invention discloses non-iodinated radiopaque microbeads that may be used in image guided embolization in a subject ailing with tumor. The non-iodinated radiopaque microbeads include a ceramic material doped with a CT contrast agent or a MRI contrast agent or both. The doped ceramic is blended with a polymer and the blend is electrosprayed to form the radiopaque microbeads. Further the radiopaque microbeads are radiolabeled with a radioactive isotope. Methods of synthesis of the radiopaque microspheres are also disclosed. The non-iodinated radiopaque microbeads with radiolabeling are capable of rendering an imageable computed tomography (CT) contrast or magnetic resonance imaging (MRI) contrast when administered in a subject. Also the microspheres are biodegradable and hence the treatment could be repeated in case of recurrence of the tumor in the subject.
Abstract:
A composition for facilitating localized delivery of energy and of therapeutic agents to a lesion in tissue is disclosed comprising nanoparticles of a polysaccharide, gelatin or a polymer, wherein the nanoparticles are complexed with tin ions. The composition may comprise one or more therapeutic agents. The composition may be configured to improve the thermal effect of RF energy on a lesion and or to release the therapeutic agents to the lesion when RF energy is applied.